Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in URGN — UroGen Pharma Ltd.

CIK 1423053 MIAMI, FL
Back to URGN Full portfolio

Position in URGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,818,567
-$12,459,701 QoQ
Shares Held
267,996
-63.7% QoQ
Ownership
0.550%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Derivatives in URGN

reported options exposure · as of Mar 31, 2026
CallValue
$275,094
CallShares
15,300
PutValue
$591,542
PutShares
32,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names. URGN ranks #125 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in URGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $275,094 15,300
2026-03-31 $591,542 32,900
2026-03-31 $4,818,567 267,996
2025-12-31 $17,278,268 737,757
2025-12-31 $1,309,178 55,900
2025-12-31 $667,470 28,500
2025-09-30 $1,711,710 85,800
2025-09-30 $1,921,185 96,300
2025-09-30 $12,015,425 602,277
2025-06-30 $2,394,760 174,800
2025-06-30 $3,788,050 276,500
2025-06-30 $7,441,785 543,196
2025-03-31 $102,858 9,300
2025-03-31 $2,097,827 189,677
2025-03-31 $787,472 71,200
2024-12-31 $614,505 57,700
2024-12-31 $2,436,560 228,785
2024-12-31 $104,370 9,800
2024-09-30 $3,074,238 242,066
2024-09-30 $624,840 49,200
2024-09-30 $124,460 9,800
2024-06-30 $1,247,793 74,362
2024-06-30 $592,334 35,300
2024-06-30 $419,500 25,000
2024-03-31 $261,000 17,400
2024-03-31 $336,000 22,400
2024-03-31 $1,077,240 71,816
2023-12-31 $315,000 21,000
2023-12-31 $2,158,185 143,879
2023-12-31 $241,500 16,100
2023-09-30 $113,481 8,100
2023-09-30 $98,013 6,996
2023-09-30 $385,275 27,500
2023-06-30 $496,592 47,980
2023-06-30 $137,655 13,300
2023-06-30 $104,535 10,100
2023-03-31 $515,592 55,800
2023-03-31 $713,105 77,176
2023-03-31 $106,260 11,500
2022-12-31 $840,876 94,800
2022-12-31 $3,548 400
2022-12-31 $434,071 48,937
2022-09-30 $114,158 13,721
2022-09-30 $165,568 19,900
2021-09-30 $963,751 57,298
2021-09-30 $597,110 35,500
2021-09-30 $618,976 36,800
2021-06-30 $1,046,743 68,549
2021-06-30 $572,625 37,500
2021-06-30 $549,720 36,000

Report a Problem

Category
Description
Email (optional, for follow-up)